Guide to Predicting Protein-Protein Interactions in the Human Proteome

Proteins rarely work alone. Most biological processes depend on physical contacts between proteins, and errors in these interactions are linked to diseases including cancer and neurodegenerative disorders. The direct answer to predicting protein-protein interactions in the human proteome is that researchers use a combination of experimental methods (such as yeast two-hybrid screens and affinity purification) and computational tools (including sequence-based algorithms, structural modeling, and machine learning) to map these connections. No single method is sufficient for the entire proteome, so the field relies on integrating multiple data sources and validation steps.

Why Protein-Protein Interactions Matter

The human proteome contains roughly 20,000 protein-coding genes, but the number of distinct protein forms is much higher due to splicing and post-translational modifications. Each protein may interact with dozens of partners, forming networks that control signaling, metabolism, and structural organization. When these interactions are disrupted, normal cellular function breaks down. For example, mutations that alter binding surfaces can lead to inappropriate signaling in cancer, while aggregation-prone proteins in Alzheimer’s disease fail to interact properly with their normal partners.

Understanding interaction networks helps researchers identify drug targets. If a disease-related protein has no obvious enzymatic activity, blocking its interaction with a partner may provide a therapeutic strategy. The challenge is that experimental mapping of all human protein interactions is incomplete and costly, which drives the need for reliable prediction methods.

Experimental Methods That Generate Training Data

Predictive algorithms depend on high-quality experimental data. Two techniques have produced the majority of known human protein interactions.

Yeast Two-Hybrid Screens

This method tests whether two proteins physically interact by expressing them as fusion proteins in yeast cells. One protein is attached to a DNA-binding domain, the other to an activation domain. If they bind, a reporter gene is turned on. This approach can screen large numbers of protein pairs, but it has a notable false-positive rate because proteins are tested outside their native cellular context.

Affinity Purification Followed by Mass Spectrometry

In this approach, a “bait” protein is tagged and expressed in human cells. The tag allows researchers to pull down the bait along with any proteins physically attached to it. Mass spectrometry identifies the captured proteins. This method preserves more natural cellular conditions than yeast two-hybrid, but it can miss transient interactions and may pull down indirect associations.

Databases such as UniProt and the National Center for Biotechnology Information curate interaction data from published experiments, making it available for training computational models.

Computational Approaches for Predicting Interactions

Predictive methods fall into several categories, each with different strengths and limitations.

Sequence-Based Prediction

These methods use the amino acid sequences of two proteins to estimate whether they interact. The underlying logic is that interacting proteins often co-evolve, meaning that mutations in one partner are compensated by changes in the other. Algorithms calculate correlation scores between sequence alignments across species. A high correlation suggests a functional or physical link.

Another sequence-based approach looks for short linear motifs on protein surfaces that are known to mediate binding. If protein A contains a motif that protein B is known to recognize, a potential interaction is flagged. Sequence methods are fast and can be applied to any protein, but they produce many false positives because sequence similarity does not guarantee actual binding.

Structure-Based Prediction

When the three-dimensional structures of two proteins are known, researchers can model whether their surfaces fit together energetically. Molecular docking algorithms generate candidate binding poses and score them based on shape complementarity and electrostatic compatibility. This approach is more accurate than sequence-only methods, but it requires structural data, which is available for only a fraction of human proteins.

For proteins without experimentally determined structures, homology modeling can create approximate structures based on related proteins. The accuracy of the prediction then depends on how closely the template matches the target.

Machine Learning and Deep Learning

Modern prediction tools train neural networks on known interaction data. Features fed into the model include sequence properties, gene co-expression patterns, co-localization in the cell, and phylogenetic profiles. Deep learning models can capture complex, non-linear relationships between these features.

A typical workflow involves splitting known interactions into training and test sets, training the model to recognize interaction patterns, then evaluating its performance on unseen pairs. State-of-the-art models achieve area under the curve (AUC) scores above 0.9 on benchmark datasets, but performance drops when applied to proteins that are dissimilar to those in the training set. The STRING database integrates many of these predictions along with experimental evidence, providing confidence scores for millions of predicted interactions.

Integrating Multiple Evidence Types

No single predictor is reliable enough for the entire proteome. The most useful tools combine several lines of evidence.

For example, a predicted interaction might receive a high confidence score only if:

• The two proteins are co-expressed in the same tissues.
• Their genes share similar functional annotations.
• Their orthologs interact in other species.
• Their structures are compatible.

STRING uses this integrated approach, assigning each predicted interaction a combined score from 0 to 1. A score above 0.7 is generally considered high confidence. Researchers can query STRING with a list of proteins and retrieve both known and predicted interactions, along with supporting evidence for each.

Validation and Common Pitfalls

A predicted interaction is a hypothesis, not a fact. Before investing time in follow-up experiments, researchers should check several potential issues.

False positives are common. A sequence-based prediction may flag two proteins that share a domain but never meet in the cell. Structural predictions can produce plausible-looking docking poses that are not energetically favorable under physiological conditions. Machine learning models can overfit to training data, learning to recognize artifacts rather than true biological signals.

False negatives also occur. Transient interactions, such as those between enzymes and their substrates, are difficult to detect experimentally and therefore underrepresented in training data. Predictors trained on stable complexes will miss these.

Experimental validation remains the gold standard. Co-immunoprecipitation followed by Western blot or mass spectrometry can confirm a predicted interaction in a specific cell type. For high-throughput validation, techniques such as proximity labeling (BioID, APEX) can capture weak or transient interactions in living cells.

Practical Workflow for Using Predictions

A typical research project might follow these steps:

1. Identify a protein of interest and compile its known interaction partners from databases.
2. Use STRING or a similar tool to generate predicted interaction candidates with high confidence scores.
3. Filter candidates by relevance: do they share tissue expression, disease associations, or functional pathways?
4. Select 5-10 top candidates for experimental testing.
5. Use co-immunoprecipitation to test each candidate in a relevant cell line.
6. Confirm positive hits with an orthogonal method, such as fluorescence resonance energy transfer (FRET) or surface plasmon resonance.

This workflow reduces the number of experiments needed while increasing the chance of finding true interactions.

Key Takeaways

• Predicting protein-protein interactions in the human proteome relies on a mix of experimental data and computational methods, including sequence analysis, structural docking, and machine learning.
• No single prediction method is sufficient; the best results come from integrating multiple evidence types, such as co-expression, co-evolution, and structural compatibility.
• Databases like STRING provide confidence-scored predictions that can prioritize candidates for experimental testing.
• Predicted interactions require validation because false positives and false negatives are common, especially for transient or context-dependent binding events.
• A practical workflow combines database queries, computational filtering, and two orthogonal experimental methods to confirm new interactions.